News
166 articles
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day One
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
Cherishing the Simple Things
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.
Don’t Let Doctors Tell You Nothing’s Wrong
After a long road to diagnosis Brandon Stone learned he has a BRCA2 genetic mutation that impacts his treatment.
Unexpected Blessings From My Pancreatic Cancer
Kelly Pankratz says she has been graced with unexpected blessings in her pancreatic cancer journey, which includes pancreatectomy surgery.
What You Should Know About Pancreatic Cysts
Dr. V. Raman Muthusamy explains the difference between pancreatic cysts and pancreatic cancer. Learn about different types of pancreatic cysts and which may develop cancer.
How to Eat with Pancreatic Cancer
What should I eat while in treatment? Oncology dietitian Maria Petzel provides eating strategies for pancreatic cancer patients.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
A Liquid Biopsy for Pancreatic Cancer
Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.
Tonsil Cancer Follow-up Finds Pancreatic Cancer
Gene Waters was fortunate that a follow-up for tonsil cancer found his pancreatic cancer early. He got a second opinion for his treatment.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
Prognosis: More Than Numbers in Pancreatic Cancer
What is pancreatic cancer prognosis? Dr. Joshua Lakin of Harvard explains how prognosis works, and ways to possibly defy the odds when facing a slow recovery.
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you.
Ready to Fight
Russell Reed lost his father-in-law to pancreatic cancer so he knew how important the right doctor would be for his own treatment.
Sometimes Things Get Worse Before They Get Better
Matthew Rosenblum thought his time was limited after a pancreatic cancer diagnosis at age 32, but he’s a BRCA2 carrier, which opened treatment options.